Citalopram

Specifications

59729-33-8CAS Number

261-891-1EC Number

1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrileIUPAC Name

C20H21FN2OChemical Formula

324.4 g/molMolecular Weight

citalopram; 59729-33-8; Nitalapram; Cipram; Citalopramum; Citadur; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; 0DHU5B8D6V; Lu 10-171; 1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile; DTXSID8022826; CHEBI:77397; Cytalopram; 5-Isobenzofurancarbonitrile, 1,3-dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-; 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-; 5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-; 1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile; 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile; 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; RefChem:5691; CHEBI:3723; DTXCID802826; N06AB04; Lu10171; 261-891-1; Cipramil; Citox; 1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; Bonitrile; [3H]Citalopram; 5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-; MFCD00865398; Lu-10-171; CHEMBL549; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile; Nitalapram HBr; [3H]-Citalopram; Citalopramum [INN-Latin]; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; 1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carb onitrile; SMR000465669; Citadur (TN); Citalopram (USP/INN); EINECS 261-891-1; UNII-0DHU5B8D6V; Citalopram [USP:INN:BAN]; [3H]Cytalopram; [3H]Escitalopram; [3H]Lexapro; (+/-)-citalopram; Citalopram-d4 oxalate; CITALOPRAM [MI]; CITALOPRAM [INN]; Prestwick3_000692; SCHEMBL946; CITALOPRAM [VANDF]; CITALOPRAM [MART.]; CITALOPRAM [WHO-DD]; Lopac0_000258; BSPBio_000843; AE-641/00603021; MLS000028578; MLS006011858; BPBio1_000929; GTPL4621; GTPL7547; orb1705387; orb2901516; orb3141297; SCHEMBL29494157; BDBM25870; HSDB 7042; WSEQXVZVJXJVFP-UHFFFAOYSA-; CITALOPRAM [USP IMPURITY]; PS18 - Citalopram/Norcitalopram; HMS2090O09; HMS2093A14; HMS3259B10; MSK10296; QXB00326; UYB90884; BBL029066; EBC-12027; LU-10171B; STL058639; AKOS005711003; AC-8894; CCG-204353; DB00215; Escitalopram EP Impurity K; Citalopram; NC00711; SDCCGSBI-0050246.P003; 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; MRF-0000302; NCGC00015267-04; NCGC00015267-05; NCGC00015267-07; NCGC00015267-09; NCGC00015267-11; NCGC00015267-12; NCGC00015267-20; NCGC00015267-26; NCGC00025160-02; AS-76503; ST069372; SY347033; SBI-0050246.P002; HY-121203; AB00513896; C3149; CS-0081223; NS00000035; C07572; D07704; EN300-304884; T20828; AB00513896-09; AB00513896-11; AB00513896_12; AB00513896_13; AE-641/00605044; F604217; L001223; Q409672; SR-01000003129-8; BRD-A47598013-004-02-0; BRD-A47598013-004-06-1; BRD-A47598013-004-16-0; BRD-A47598013-004-17-8; BRD-A47598013-004-18-6; BRD-A47598013-034-02-7; CitalopramCipram, Lu 10-171, Lu-10-171 Lu10-171; CitalopramLu-10-171 Lu10-171, Lu 10-171, Cipram; 1-(3'-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; 1-(3-(dimethylamino)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; 1-[3-(dimethylamino) propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile; 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro[3,4]benzofuran-5-carbonitrile; 5-Cyano-1-(4-fluorophenyl)-1-(3-dimethylaminopropyl)-1,3-dihydro-isobenzofuran; InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3Synonyms